Search company, investor...
Lexogen company logo


Founded Year



Grant | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+60 points in the past 30 days

About Lexogen

Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest.

Headquarters Location

Campus Vienna Biocenter 5

Vienna, 1030,


+43 (0) 1 345 1212

Missing: Lexogen's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Lexogen's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Lexogen Patents

Lexogen has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • DNA
  • Molecular biology
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics


Application Date


Grant Date



Related Topics

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics



Latest Lexogen News

New Products Posted to GenomeWeb: IDT, Lexogen, Thermo Fisher, More

Sep 2, 2022

Save for later IDT xGen Monkeypox Virus Amplicon Panel IDT has launched a next-generation sequencing library prep kit for monkeypox virus genotyping. The xGen Monkeypox Virus Amplicon Panel offers a single-tube workflow that takes 2.5 hours, and generates contiguous tiling of overlapping amplicons. Super amplicons enable novel variant discovery by maintaining genomic coverage even if a novel variant occurs under a primer binding site, which may disrupt a primer's ability to bind, the company noteed. The research-use-only kit is also compatible with IDT Normalase technology for normalization of NGS libraries. Lexogen RiboCop rRNA Depletion Kit for Yeast Lexogen has released its RiboCop rRNA Depletion Kit for Yeast. Total RNA is composed of large amounts of undesired ribosomal RNA (rRNA), which accounts for up to 95 percent of all transcripts in an RNA sample, Lexogen said. The RiboCop rRNA Depletion Kit for Yeast enables efficient removal of this rRNA so that equencing reads are focused to RNA of interest, which allows more samples to be multiplexed and significantly reduces the sequencing cost per sample, the company said. RiboCop's rRNA depletion technology is based on hybridization of rRNA to specifically designed oligos and removal with magnetic beads. Lexogen has also developed an algorithm to design specific probe mixes for maximum rRNA removal while keeping unwanted off-target effects at a minimum and preserving unbiased expression profiles. RiboCop is compatible with CORALL RNA-Seq V2 and all standard RNA-Seq library preparation protocols, the company said. Thermo Fisher Scientific Orbitrap Ascend Tribrid Mass Spectrometer, μPAC HPLC columns Thermo Fisher Scientific has launched its Orbitrap Ascend Tribrid mass spectrometer targeting the proteomics and biopharma markets. The instrument features the Tribrid architecture, which includes a quadrupole, linear ion trap, and Orbitrap HRAM along with multiple fragmentation techniques including CID, HCD, UVPD, ETD, and PCTR. The instrument's architecture allows it to route multiple sets of ions simultaneously. The Orbitrap analyzer offers resolution up to 480,000 (FWHM) at m/z 200 and an acquisition rate of up to 45 Hz. The instrument also offers an optimal high mass range feature that allows for analysis of molecules with m/z of up to 16,000. The company also announced the release of several new μPAC HPLC columns: its 50 cm Low-Load μPAC Neo HPLC column for single cell and multiplexed sample analysis, and its 110 cm μPAC Neo HPLC column for deep dive proteomics analysis. For more new products and services, please visit the New Products page on our website.

Lexogen Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Lexogen Rank

Lexogen Frequently Asked Questions (FAQ)

  • When was Lexogen founded?

    Lexogen was founded in 2007.

  • Where is Lexogen's headquarters?

    Lexogen's headquarters is located at Campus Vienna Biocenter 5, Vienna.

  • What is Lexogen's latest funding round?

    Lexogen's latest funding round is Grant.

  • Who are the investors of Lexogen?

    Investors of Lexogen include FFG.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.